Structure

Physi-Chem Properties

Molecular Weight:  406.04
Volume:  357.39
LogP:  4.343
LogD:  3.687
LogS:  -4.129
# Rotatable Bonds:  3
TPSA:  80.49
# H-Bond Aceptor:  5
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.344
Synthetic Accessibility Score:  3.329
Fsp3:  0.05
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.148
MDCK Permeability:  4.779477421834599e-06
Pgp-inhibitor:  0.004
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.017
20% Bioavailability (F20%):  0.061
30% Bioavailability (F30%):  0.566

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.117
Plasma Protein Binding (PPB):  97.9762954711914%
Volume Distribution (VD):  0.908
Pgp-substrate:  1.47665274143219%

ADMET: Metabolism

CYP1A2-inhibitor:  0.929
CYP1A2-substrate:  0.22
CYP2C19-inhibitor:  0.955
CYP2C19-substrate:  0.061
CYP2C9-inhibitor:  0.905
CYP2C9-substrate:  0.909
CYP2D6-inhibitor:  0.956
CYP2D6-substrate:  0.653
CYP3A4-inhibitor:  0.949
CYP3A4-substrate:  0.267

ADMET: Excretion

Clearance (CL):  3.261
Half-life (T1/2):  0.519

ADMET: Toxicity

hERG Blockers:  0.685
Human Hepatotoxicity (H-HT):  0.174
Drug-inuced Liver Injury (DILI):  0.598
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.96
Maximum Recommended Daily Dose:  0.989
Skin Sensitization:  0.185
Carcinogencity:  0.021
Eye Corrosion:  0.003
Eye Irritation:  0.023
Respiratory Toxicity:  0.897

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473218

Natural Product ID:  NPC473218
Common Name*:   Spongotine B
IUPAC Name:   (6-bromo-1H-indol-3-yl)-[5-(1H-indol-3-yl)-4,5-dihydro-1H-imidazol-2-yl]methanone
Synonyms:  
Standard InCHIKey:  CIFUWIGYZJXRFR-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C20H15BrN4O/c21-11-5-6-13-15(9-23-17(13)7-11)19(26)20-24-10-18(25-20)14-8-22-16-4-2-1-3-12(14)16/h1-9,18,22-23H,10H2,(H,24,25)
SMILES:  C1C(NC(=N1)C(=O)C2=CNC3=C2C=CC(=C3)Br)C4=CNC5=CC=CC=C54
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL373574
PubChem CID:   16104848
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0002497] Indoles
          • [CHEMONTID:0004196] 3-alkylindoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[15921415]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[16154746]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[17253840]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. southern australian n.a. PMID[9599272]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 > 30.0 ug ml-1 PMID[490422]
NPT146 Cell Line SK-OV-3 Homo sapiens ED50 > 30.0 ug ml-1 PMID[490422]
NPT147 Cell Line SK-MEL-2 Homo sapiens ED50 > 30.0 ug ml-1 PMID[490422]
NPT574 Cell Line XF498 Homo sapiens ED50 > 30.0 ug ml-1 PMID[490422]
NPT148 Cell Line HCT-15 Homo sapiens ED50 > 30.0 ug ml-1 PMID[490422]
NPT19 Organism Escherichia coli Escherichia coli MIC > 25.0 ug.mL-1 PMID[490422]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 25.0 ug.mL-1 PMID[490422]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium MIC > 25.0 ug.mL-1 PMID[490422]
NPT1531 Organism Enterococcus faecium Enterococcus faecium MIC > 25.0 ug.mL-1 PMID[490422]
NPT1033 Organism Enterobacter cloacae Enterobacter cloacae MIC > 25.0 ug.mL-1 PMID[490422]
NPT720 Organism Enterobacter aerogenes Enterobacter aerogenes MIC > 25.0 ug.mL-1 PMID[490422]
NPT1228 Organism Streptococcus pyogenes Streptococcus pyogenes MIC = 25.0 ug.mL-1 PMID[490422]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 25.0 ug.mL-1 PMID[490422]
NPT19 Organism Escherichia coli Escherichia coli MIC = 25.0 ug.mL-1 PMID[490422]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 25.0 ug.mL-1 PMID[490422]
NPT4997 Organism Klebsiella oxytoca Klebsiella oxytoca MIC = 25.0 ug.mL-1 PMID[490422]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473218 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470702
0.9947 High Similarity NPC470703
0.8894 High Similarity NPC935
0.8894 High Similarity NPC267078
0.8852 High Similarity NPC474357
0.8756 High Similarity NPC470323
0.8571 High Similarity NPC237414
0.8571 High Similarity NPC477004
0.8477 Intermediate Similarity NPC220797
0.8477 Intermediate Similarity NPC153123
0.8477 Intermediate Similarity NPC475914
0.8477 Intermediate Similarity NPC474318
0.8477 Intermediate Similarity NPC201266
0.8477 Intermediate Similarity NPC268744
0.8434 Intermediate Similarity NPC269203
0.8434 Intermediate Similarity NPC77241
0.8434 Intermediate Similarity NPC166209
0.8434 Intermediate Similarity NPC13456
0.8404 Intermediate Similarity NPC284775
0.8316 Intermediate Similarity NPC326422
0.8316 Intermediate Similarity NPC304203
0.8281 Intermediate Similarity NPC110158
0.8269 Intermediate Similarity NPC267811
0.8241 Intermediate Similarity NPC474389
0.8214 Intermediate Similarity NPC476460
0.8146 Intermediate Similarity NPC116555
0.8131 Intermediate Similarity NPC188821
0.8131 Intermediate Similarity NPC474180
0.7958 Intermediate Similarity NPC477611
0.7951 Intermediate Similarity NPC317701
0.7908 Intermediate Similarity NPC477003
0.7897 Intermediate Similarity NPC191415
0.7778 Intermediate Similarity NPC99939
0.7778 Intermediate Similarity NPC308931
0.7736 Intermediate Similarity NPC471194
0.7736 Intermediate Similarity NPC471193
0.7727 Intermediate Similarity NPC156003
0.7716 Intermediate Similarity NPC307191
0.7677 Intermediate Similarity NPC117027
0.7677 Intermediate Similarity NPC102755
0.7676 Intermediate Similarity NPC77101
0.7659 Intermediate Similarity NPC167710
0.7638 Intermediate Similarity NPC21429
0.7633 Intermediate Similarity NPC23420
0.7633 Intermediate Similarity NPC106771
0.7633 Intermediate Similarity NPC303820
0.7633 Intermediate Similarity NPC205254
0.7619 Intermediate Similarity NPC82053
0.7606 Intermediate Similarity NPC72956
0.7604 Intermediate Similarity NPC17751
0.7604 Intermediate Similarity NPC42372
0.7602 Intermediate Similarity NPC474958
0.7596 Intermediate Similarity NPC52909
0.7596 Intermediate Similarity NPC475935
0.7596 Intermediate Similarity NPC94211
0.7576 Intermediate Similarity NPC88110
0.7576 Intermediate Similarity NPC16659
0.757 Intermediate Similarity NPC153980
0.757 Intermediate Similarity NPC6865
0.7558 Intermediate Similarity NPC475736
0.7537 Intermediate Similarity NPC231536
0.7525 Intermediate Similarity NPC265710
0.7513 Intermediate Similarity NPC274229
0.75 Intermediate Similarity NPC19696
0.75 Intermediate Similarity NPC37152
0.75 Intermediate Similarity NPC136957
0.7489 Intermediate Similarity NPC474195
0.7488 Intermediate Similarity NPC473666
0.7488 Intermediate Similarity NPC174281
0.7488 Intermediate Similarity NPC475286
0.7475 Intermediate Similarity NPC240088
0.7475 Intermediate Similarity NPC473380
0.7465 Intermediate Similarity NPC471192
0.7463 Intermediate Similarity NPC108011
0.7462 Intermediate Similarity NPC293216
0.746 Intermediate Similarity NPC141926
0.7451 Intermediate Similarity NPC324091
0.7449 Intermediate Similarity NPC82331
0.7437 Intermediate Similarity NPC276540
0.7437 Intermediate Similarity NPC233050
0.7432 Intermediate Similarity NPC474196
0.7404 Intermediate Similarity NPC471536
0.7398 Intermediate Similarity NPC471943
0.7389 Intermediate Similarity NPC200553
0.7389 Intermediate Similarity NPC279189
0.7379 Intermediate Similarity NPC477167
0.7379 Intermediate Similarity NPC477166
0.7379 Intermediate Similarity NPC473342
0.7379 Intermediate Similarity NPC304187
0.7371 Intermediate Similarity NPC247987
0.7368 Intermediate Similarity NPC131887
0.7363 Intermediate Similarity NPC275292
0.7363 Intermediate Similarity NPC243381
0.7356 Intermediate Similarity NPC329765
0.7356 Intermediate Similarity NPC476526
0.7356 Intermediate Similarity NPC48117
0.7343 Intermediate Similarity NPC88315
0.734 Intermediate Similarity NPC133003
0.7327 Intermediate Similarity NPC470205
0.7325 Intermediate Similarity NPC174489
0.7323 Intermediate Similarity NPC252572
0.7321 Intermediate Similarity NPC227582
0.7317 Intermediate Similarity NPC321708
0.731 Intermediate Similarity NPC97343
0.7309 Intermediate Similarity NPC229893
0.7293 Intermediate Similarity NPC162002
0.7287 Intermediate Similarity NPC288838
0.7286 Intermediate Similarity NPC67288
0.7286 Intermediate Similarity NPC280297
0.7277 Intermediate Similarity NPC470677
0.7261 Intermediate Similarity NPC26641
0.7251 Intermediate Similarity NPC74413
0.725 Intermediate Similarity NPC151635
0.7248 Intermediate Similarity NPC207020
0.7245 Intermediate Similarity NPC280864
0.7217 Intermediate Similarity NPC252338
0.7216 Intermediate Similarity NPC92796
0.7216 Intermediate Similarity NPC135141
0.7212 Intermediate Similarity NPC216550
0.721 Intermediate Similarity NPC17487
0.721 Intermediate Similarity NPC201831
0.7206 Intermediate Similarity NPC467063
0.7198 Intermediate Similarity NPC154339
0.7195 Intermediate Similarity NPC477114
0.7194 Intermediate Similarity NPC274981
0.719 Intermediate Similarity NPC79356
0.719 Intermediate Similarity NPC102592
0.7179 Intermediate Similarity NPC477107
0.7179 Intermediate Similarity NPC477108
0.7179 Intermediate Similarity NPC477109
0.7177 Intermediate Similarity NPC19342
0.7173 Intermediate Similarity NPC53947
0.7162 Intermediate Similarity NPC63031
0.7157 Intermediate Similarity NPC115232
0.715 Intermediate Similarity NPC260900
0.7143 Intermediate Similarity NPC157828
0.7143 Intermediate Similarity NPC476524
0.7143 Intermediate Similarity NPC476525
0.7143 Intermediate Similarity NPC195239
0.7137 Intermediate Similarity NPC63109
0.7136 Intermediate Similarity NPC17273
0.7136 Intermediate Similarity NPC141612
0.7136 Intermediate Similarity NPC135601
0.7136 Intermediate Similarity NPC282247
0.713 Intermediate Similarity NPC471191
0.7129 Intermediate Similarity NPC47190
0.7129 Intermediate Similarity NPC272458
0.7128 Intermediate Similarity NPC474492
0.7117 Intermediate Similarity NPC27041
0.7114 Intermediate Similarity NPC469529
0.7109 Intermediate Similarity NPC128244
0.7109 Intermediate Similarity NPC179701
0.7109 Intermediate Similarity NPC11445
0.7107 Intermediate Similarity NPC149265
0.7107 Intermediate Similarity NPC317105
0.7101 Intermediate Similarity NPC17059
0.71 Intermediate Similarity NPC54214
0.71 Intermediate Similarity NPC97902
0.7098 Intermediate Similarity NPC276657
0.7095 Intermediate Similarity NPC267343
0.7087 Intermediate Similarity NPC207686
0.7077 Intermediate Similarity NPC216643
0.7075 Intermediate Similarity NPC262898
0.707 Intermediate Similarity NPC473761
0.707 Intermediate Similarity NPC476073
0.7062 Intermediate Similarity NPC34844
0.7059 Intermediate Similarity NPC477610
0.7056 Intermediate Similarity NPC470203
0.7056 Intermediate Similarity NPC242116
0.7053 Intermediate Similarity NPC63571
0.7053 Intermediate Similarity NPC94752
0.7053 Intermediate Similarity NPC476527
0.7045 Intermediate Similarity NPC82370
0.7035 Intermediate Similarity NPC49217
0.7031 Intermediate Similarity NPC2272
0.7019 Intermediate Similarity NPC278434
0.7019 Intermediate Similarity NPC310633
0.7014 Intermediate Similarity NPC477413
0.701 Intermediate Similarity NPC325903
0.701 Intermediate Similarity NPC11126
0.7005 Intermediate Similarity NPC100104
0.7005 Intermediate Similarity NPC470680
0.7005 Intermediate Similarity NPC15102
0.7005 Intermediate Similarity NPC470204
0.7 Intermediate Similarity NPC138370
0.6986 Remote Similarity NPC103119
0.6985 Remote Similarity NPC233380
0.6981 Remote Similarity NPC202812
0.6976 Remote Similarity NPC477042
0.6976 Remote Similarity NPC79777
0.6976 Remote Similarity NPC73994
0.6971 Remote Similarity NPC111566
0.697 Remote Similarity NPC214106
0.6966 Remote Similarity NPC235685
0.6961 Remote Similarity NPC237188
0.6961 Remote Similarity NPC59269
0.6961 Remote Similarity NPC157583
0.6957 Remote Similarity NPC228835
0.695 Remote Similarity NPC114637
0.6939 Remote Similarity NPC74357

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473218 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7874 Intermediate Similarity NPD2008 Discontinued
0.782 Intermediate Similarity NPD2411 Approved
0.7547 Intermediate Similarity NPD2443 Approved
0.7547 Intermediate Similarity NPD2442 Approved
0.7476 Intermediate Similarity NPD2879 Approved
0.7476 Intermediate Similarity NPD2881 Approved
0.7463 Intermediate Similarity NPD3607 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD6180 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD2408 Discontinued
0.7349 Intermediate Similarity NPD1600 Suspended
0.7336 Intermediate Similarity NPD3905 Phase 3
0.7295 Intermediate Similarity NPD4922 Phase 2
0.722 Intermediate Similarity NPD4426 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD8248 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD4848 Phase 1
0.7176 Intermediate Similarity NPD1506 Discontinued
0.7143 Intermediate Similarity NPD2481 Approved
0.7143 Intermediate Similarity NPD2479 Phase 3
0.7143 Intermediate Similarity NPD2509 Approved
0.7143 Intermediate Similarity NPD5473 Discontinued
0.7143 Intermediate Similarity NPD2510 Approved
0.7123 Intermediate Similarity NPD1982 Phase 1
0.7101 Intermediate Similarity NPD4988 Discontinued
0.7095 Intermediate Similarity NPD460 Discontinued
0.7078 Intermediate Similarity NPD4051 Discontinued
0.7075 Intermediate Similarity NPD6664 Approved
0.7064 Intermediate Similarity NPD6459 Phase 2
0.7062 Intermediate Similarity NPD7619 Phase 3
0.7062 Intermediate Similarity NPD7618 Phase 3
0.7059 Intermediate Similarity NPD1291 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD5199 Approved
0.7054 Intermediate Similarity NPD5198 Approved
0.7045 Intermediate Similarity NPD8013 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD4614 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7564 Discontinued
0.703 Intermediate Similarity NPD4128 Approved
0.7024 Intermediate Similarity NPD1895 Discontinued
0.7005 Intermediate Similarity NPD5426 Phase 3
0.7 Intermediate Similarity NPD7809 Clinical (unspecified phase)
0.6995 Remote Similarity NPD2880 Discontinued
0.6987 Remote Similarity NPD6165 Phase 2
0.6987 Remote Similarity NPD6164 Phase 2
0.6976 Remote Similarity NPD6595 Phase 3
0.6968 Remote Similarity NPD4863 Approved
0.6961 Remote Similarity NPD4181 Approved
0.6948 Remote Similarity NPD2290 Phase 3
0.6948 Remote Similarity NPD2289 Phase 3
0.6941 Remote Similarity NPD8493 Clinical (unspecified phase)
0.6933 Remote Similarity NPD6470 Phase 3
0.692 Remote Similarity NPD3389 Approved
0.692 Remote Similarity NPD3394 Approved
0.692 Remote Similarity NPD3393 Approved
0.6916 Remote Similarity NPD5446 Phase 2
0.691 Remote Similarity NPD8047 Clinical (unspecified phase)
0.6908 Remote Similarity NPD5728 Clinical (unspecified phase)
0.689 Remote Similarity NPD5820 Clinical (unspecified phase)
0.6889 Remote Similarity NPD8000 Clinical (unspecified phase)
0.6881 Remote Similarity NPD2121 Clinical (unspecified phase)
0.6878 Remote Similarity NPD7704 Clinical (unspecified phase)
0.6878 Remote Similarity NPD6203 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6481 Clinical (unspecified phase)
0.6872 Remote Similarity NPD1996 Discontinued
0.6863 Remote Similarity NPD482 Approved
0.686 Remote Similarity NPD4011 Clinical (unspecified phase)
0.6856 Remote Similarity NPD4374 Clinical (unspecified phase)
0.6849 Remote Similarity NPD4299 Phase 1
0.6849 Remote Similarity NPD6288 Clinical (unspecified phase)
0.6844 Remote Similarity NPD4851 Clinical (unspecified phase)
0.6842 Remote Similarity NPD6610 Clinical (unspecified phase)
0.6833 Remote Similarity NPD7666 Phase 3
0.6833 Remote Similarity NPD7665 Phase 2
0.6829 Remote Similarity NPD4075 Phase 2
0.6827 Remote Similarity NPD3318 Approved
0.6827 Remote Similarity NPD3320 Approved
0.6827 Remote Similarity NPD3319 Phase 1
0.6822 Remote Similarity NPD5855 Phase 3
0.6822 Remote Similarity NPD5853 Phase 3
0.6809 Remote Similarity NPD198 Clinical (unspecified phase)
0.6802 Remote Similarity NPD2295 Clinical (unspecified phase)
0.6794 Remote Similarity NPD2096 Phase 2
0.6794 Remote Similarity NPD2091 Phase 2
0.6791 Remote Similarity NPD7027 Phase 3
0.6789 Remote Similarity NPD786 Approved
0.6777 Remote Similarity NPD3961 Discontinued
0.6774 Remote Similarity NPD6999 Discontinued
0.6774 Remote Similarity NPD7000 Clinical (unspecified phase)
0.6774 Remote Similarity NPD5854 Approved
0.6773 Remote Similarity NPD7208 Approved
0.6773 Remote Similarity NPD7209 Approved
0.6773 Remote Similarity NPD7207 Approved
0.6771 Remote Similarity NPD7998 Clinical (unspecified phase)
0.6771 Remote Similarity NPD2007 Clinical (unspecified phase)
0.6765 Remote Similarity NPD3347 Clinical (unspecified phase)
0.6759 Remote Similarity NPD1952 Discontinued
0.6756 Remote Similarity NPD6787 Phase 2
0.6749 Remote Similarity NPD1343 Approved
0.6748 Remote Similarity NPD749 Clinical (unspecified phase)
0.6746 Remote Similarity NPD2094 Phase 2
0.6746 Remote Similarity NPD2092 Phase 2
0.6746 Remote Similarity NPD2095 Phase 2
0.6745 Remote Similarity NPD7175 Phase 1
0.6744 Remote Similarity NPD7024 Clinical (unspecified phase)
0.674 Remote Similarity NPD8406 Clinical (unspecified phase)
0.6735 Remote Similarity NPD2172 Phase 1
0.673 Remote Similarity NPD7026 Phase 2
0.6726 Remote Similarity NPD7971 Clinical (unspecified phase)
0.6726 Remote Similarity NPD7970 Approved
0.6725 Remote Similarity NPD6579 Phase 2
0.6719 Remote Similarity NPD1722 Approved
0.6713 Remote Similarity NPD1851 Clinical (unspecified phase)
0.6713 Remote Similarity NPD6278 Clinical (unspecified phase)
0.6712 Remote Similarity NPD5017 Discontinued
0.6712 Remote Similarity NPD7903 Clinical (unspecified phase)
0.6711 Remote Similarity NPD7594 Clinical (unspecified phase)
0.6711 Remote Similarity NPD8458 Clinical (unspecified phase)
0.671 Remote Similarity NPD7661 Clinical (unspecified phase)
0.6698 Remote Similarity NPD3486 Clinical (unspecified phase)
0.6698 Remote Similarity NPD3246 Discontinued
0.6697 Remote Similarity NPD5901 Discontinued
0.6697 Remote Similarity NPD7621 Clinical (unspecified phase)
0.6683 Remote Similarity NPD2590 Clinical (unspecified phase)
0.6681 Remote Similarity NPD8488 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5415 Approved
0.6667 Remote Similarity NPD8256 Approved
0.6667 Remote Similarity NPD7001 Phase 3
0.6667 Remote Similarity NPD2837 Discontinued
0.6667 Remote Similarity NPD8257 Approved
0.6667 Remote Similarity NPD6454 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8258 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2390 Clinical (unspecified phase)
0.6653 Remote Similarity NPD3360 Clinical (unspecified phase)
0.6652 Remote Similarity NPD8112 Clinical (unspecified phase)
0.6651 Remote Similarity NPD3431 Approved
0.6651 Remote Similarity NPD6277 Clinical (unspecified phase)
0.6651 Remote Similarity NPD2793 Discontinued
0.6651 Remote Similarity NPD6217 Discontinued
0.6651 Remote Similarity NPD7098 Clinical (unspecified phase)
0.6651 Remote Similarity NPD3430 Approved
0.6639 Remote Similarity NPD3914 Clinical (unspecified phase)
0.6639 Remote Similarity NPD6986 Phase 1
0.6637 Remote Similarity NPD6838 Clinical (unspecified phase)
0.6637 Remote Similarity NPD7656 Approved
0.6637 Remote Similarity NPD7657 Approved
0.6636 Remote Similarity NPD2960 Clinical (unspecified phase)
0.6636 Remote Similarity NPD5686 Approved
0.6636 Remote Similarity NPD7817 Phase 1
0.6636 Remote Similarity NPD5685 Approved
0.6636 Remote Similarity NPD7818 Clinical (unspecified phase)
0.6633 Remote Similarity NPD1270 Approved
0.6622 Remote Similarity NPD6229 Phase 2
0.662 Remote Similarity NPD2009 Clinical (unspecified phase)
0.6619 Remote Similarity NPD1708 Approved
0.6619 Remote Similarity NPD1707 Approved
0.6619 Remote Similarity NPD4649 Clinical (unspecified phase)
0.6618 Remote Similarity NPD5065 Approved
0.6608 Remote Similarity NPD4341 Clinical (unspecified phase)
0.6606 Remote Similarity NPD4924 Clinical (unspecified phase)
0.6605 Remote Similarity NPD1658 Discontinued
0.6605 Remote Similarity NPD5592 Clinical (unspecified phase)
0.6601 Remote Similarity NPD3583 Phase 2
0.6599 Remote Similarity NPD3100 Discontinued
0.6594 Remote Similarity NPD5643 Phase 2
0.6593 Remote Similarity NPD6152 Phase 1
0.6592 Remote Similarity NPD6732 Clinical (unspecified phase)
0.6589 Remote Similarity NPD1284 Clinical (unspecified phase)
0.6588 Remote Similarity NPD1332 Clinical (unspecified phase)
0.6587 Remote Similarity NPD2367 Phase 2
0.6585 Remote Similarity NPD5069 Clinical (unspecified phase)
0.658 Remote Similarity NPD6210 Phase 3
0.657 Remote Similarity NPD750 Phase 2
0.6564 Remote Similarity NPD7454 Approved
0.6564 Remote Similarity NPD6954 Phase 2
0.6564 Remote Similarity NPD7455 Approved
0.6562 Remote Similarity NPD3840 Phase 2
0.6562 Remote Similarity NPD3839 Phase 2
0.6561 Remote Similarity NPD6837 Clinical (unspecified phase)
0.656 Remote Similarity NPD7023 Clinical (unspecified phase)
0.6558 Remote Similarity NPD3871 Clinical (unspecified phase)
0.6558 Remote Similarity NPD3870 Clinical (unspecified phase)
0.6552 Remote Similarity NPD1853 Clinical (unspecified phase)
0.6547 Remote Similarity NPD6987 Phase 1
0.6545 Remote Similarity NPD6137 Clinical (unspecified phase)
0.6537 Remote Similarity NPD1248 Discontinued
0.6524 Remote Similarity NPD5001 Clinical (unspecified phase)
0.652 Remote Similarity NPD3323 Discontinued
0.652 Remote Similarity NPD7470 Discontinued
0.6518 Remote Similarity NPD4023 Clinical (unspecified phase)
0.6513 Remote Similarity NPD4637 Clinical (unspecified phase)
0.6512 Remote Similarity NPD5016 Approved
0.6509 Remote Similarity NPD6242 Discontinued
0.6505 Remote Similarity NPD2185 Clinical (unspecified phase)
0.65 Remote Similarity NPD7459 Phase 2
0.6498 Remote Similarity NPD1896 Approved
0.6494 Remote Similarity NPD4541 Clinical (unspecified phase)
0.6491 Remote Similarity NPD4852 Phase 2
0.6481 Remote Similarity NPD1905 Clinical (unspecified phase)
0.6481 Remote Similarity NPD5145 Clinical (unspecified phase)
0.648 Remote Similarity NPD6458 Discontinued
0.6476 Remote Similarity NPD2144 Approved
0.6476 Remote Similarity NPD6204 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data